FI
ARKG icon

FormulaFolio Investments’s ARK Genomic Revolution ETF ARKG Stock Holding History

FormulaFolio Investments’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$66K Hold
718
– – 0.02% 129
2021
Q1 		$55K Sell
718
-150,908
-100% -$15M 0.02% 136
2020
Q4 		$14.1M Buy
+151,626
New +$12.1M 0.3% 74

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SDH
Sloy Dahl & Holst Vancouver, Washington $728M AUM 37.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

FormulaFolio Investments's ARKG Position: Q2 2021 in Review

FormulaFolio Investments held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2021 at 718 shares worth $66K. The position accounts for 0.02% of the portfolio, ranked #129.

FormulaFolio Investments first reported a position in ARKG in Q4 2020 and has held it in 3 quarters since. The position peaked at $14.1M in Q4 2020. 512 funds tracked by Wall St. Rank hold ARKG as of Q2 2021.

  • FormulaFolio Investments held 718 shares of ARK Genomic Revolution ETF worth $66K as of Q2 2021.
  • FormulaFolio Investments left its ARK Genomic Revolution ETF share count unchanged in Q2 2021.
  • ARK Genomic Revolution ETF made up 0.02% of FormulaFolio Investments's portfolio in Q2 2021, its #129 holding.
  • FormulaFolio Investments first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 3 quarters since.
  • FormulaFolio Investments's ARK Genomic Revolution ETF position peaked at $14.1M in Q4 2020.
  • 512 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2021.

Based on FormulaFolio Investments's 13F filing for Q2 2021, filed 28 Jul 2021.